Marisol Ocegueda Email

Material Tech 3 . Nektar Therapeutics

Current Roles

Employees:
627
Revenue:
$100.4M
About
Nektar Therapeutics is a research-based development stage biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet medical need. Our R&D pipeline of new investigational drugs includes treatments for cancer, auto-immune disease and chronic pain. We leverage Nektar's proprietary and proven chemistry platform in the discovery and design of our new drug candidates.
Nektar Therapeutics Address
455 Mission Bay Boulevard South
San Francisco, CA
United States
Nektar Therapeutics Email

Past Companies

NektarMaterial Tech 3
Nektar TherapeuticsMaterial tech 3